News for Health Professionals Archive - April 2008
Get news by email or subscribe to our news feeds.
April 1, 2008
- Bayer Appeals Invalidity Ruling on Its Yasmin Patent Appeal Will Be Heard by the Federal Circuit
- Senator Grassley Asks Merck, Schering-Plough Additional QuestionsAbout Vytorin Study
- Takeda Joins the HRP Initiative to Discover Biomarkers of High-Risk Atherosclerotic Plaque
- EU Advocate General Ruiz-jarabo Maintains That a Pharmaceutical Company Holding a Dominant Position Which Refuses to Meet the Orders of Wholesalers, in Order to Limit Parallel Trade, Engages in Abusive Practice
- Connecticut Attorney General Sues U.S. Food And Drug Administration Over Oxycontin
- Pfizer Successfully Completes Tender Offer for Shares of Encysive Pharmaceuticals Inc. and Announces Subsequent Offer Period
- Roche NimbleGen Launches NimbleGen Sequence Capture Technology for Targeted Genome Resequencing
April 2, 2008
- Further Data Needed to Determine Risk of Heart Attack with Abacavir
- Consumer Reports Poll: Most Say TV Drug Ads Should Include Info on How to Report Side Effects
- FDA MedWatch- Relenza (zanamivir) Changes To The WARNINGS AND PRECAUTIONS Sections Of Prescribing Information For Relenza About Postmarketing Reports Of Neurologic And Behavioral Symptoms
April 3, 2008
- Zelnorm (tegaserod maleate) Information
- Dendreon Announces $47 Million Registered Direct Offering
- Schering-Plough Launches Productivity Transformation Program To Confront New Challenges
- Eisai to Resume Clinical Study to Evaluate E2012 as a Potential Next Generation Alzheimer's Disease Treatment
- Chugai: Reinforcement of Structure for the European Sales Bases
April 4, 2008
- Abraxis BioScience Acquires Shimoda Biotech and Platco Technologies
- Takeda Wins Definitive Decision in Patent Infringement Litigation on Appeal against an ANDA Filer for Generic Actos
- Grassley Questions Increases in Drug Maker Rebates to Physicians Prescribing Anti-Anemia Drugs
- Forsteo Receives Approval from the European Commission for the Treatment of Glucocorticoid-Induced Osteoporosis
April 7, 2008
- Novartis to Acquire 25 Percent Minority Stake in Alcon from Nestle
- Novartis to Acquire 25 Percent Minority Stake in Alcon from Nestle
- Pfizer Reports Shares of Encysive Pharmaceuticals Inc. Tendered Pursuant to Guaranteed Delivery Procedures
- Keryx Biopharmaceuticals Announces Implementation of Strategic Restructuring Plan
April 8, 2008
- Repligen Announces Settlement with Bristol-Myers Squibb in Orencia Lawsuit
- Boehringer Ingelheim outpaces the market yet again in 2007
- Bristol-Myers Squibb Selects Isis Drug Targeting PCSK9 as Development Candidate for Prevention and Treatment of Cardiovascular Disease
- Alligator Blood May Put the Bite on Antibiotic-Resistant Infections
- Pfizer Extends Subsequent Offering Period of Tender Offer for Shares of Encysive Pharmaceuticals
- EFPIA Calls on EU Institutions to Reform Patient Information Rules Without Further Delay
- Durect Provides Update on Chronogesic Research Program
- GlaxoSmithKline Confirms Receipt of FDA Letter on Regulatory Reporting
April 9, 2008
- Neurogen Announces $30.6 Million Financing to Advance Clinical Development Programs
- Nektar Terminates All Negotiations With Potential Partners for Inhaled Insulin; Increased Number of Lung Cancer Cases Observed in Ongoing Clinical Studies of Inhaled Insulin Patients
- Abraxis BioScience Announces Approval to Market Abraxane for Metastatic Breast Cancer in Korea
- VaxGen Restructures Following Termination of Proposed Merger
- Novacea Receives Notification From Schering-Plough of Termination of Collaboration Agreement
- Pfizer Statement on Exubera Labeling Update in the United States
- Harvard Announces Pioneering Collaboration with Merck & Co., Inc. to Advance Osteoporosis Research
April 10, 2008
- Takeda to Acquire Millennium for US$25.00 Per Share in an All Cash Tender Offer Valued at $8.8 Billion
- Celera Grants License to Merck & Co., Inc. for Cancer Targets
- ISTA Pharmaceuticals Announces Receipt of Subpoena Relating to Promotional Practices for Xibrom
- FDA MedWatch-Exubera (insulin human rDNA origin) Inhalation Powder-Prescribing Information Updated To Include Information About Primary Lung Malignancies In Patients In Clinical Trials
- FDA MedWatch-Neupro (rotigotine transdermal system)- Product Recalled Due To The Formation Of Rotigotine Crystals In The Patches
- Pharma's Direct-to-Consumer Marketing Continues Shift to Physician Offices, Online Programs
- ArQule Provides Clinical Update on E2F-1 Program
- Pregnancy and Cancer Top the List Of the Most Commonly Searched Health Conditions
- Biovail Announces Withdrawal of Legal Action by Eugene Melnyk
- FDA issues a Communication About an Ongoing Safety Review of CellCept and Myfortic
- DMA Forecasts $10.6 Billion in 2008 Pharmaceutical Sales via Direct Marketing; New Report Focuses on Pharmaceutical Industry
- Genentech Announces First Quarter 2008 Results
April 11, 2008
- Status of the E2007 (perampanel) Development Program
- AEterna Zentaris Announces Changes to its Management Team
- Leslie J. Browne Resigns as President and Chief Executive Officer of Pharmacopeia, Inc.
- PDL BioPharma Declares $500 Million Special Cash Dividend and Announces Plan to Separate Its Biotechnology Operations From Its Antibody Humanization Royalty Assets
- PDI Signs Promotion Agreement with Major Pharmaceutical Company
April 14, 2008
- Alcon Announces Plans to Build Pharmaceutical Manufacturing Plant in Singapore
- Teva Announces Brussels Court Decision To Revoke MSD's European Patent On Fosamax
- Responses From Pharmaceutical Drug and Device Makers to Grassley Request for Disclosure of Support for Continuing Medical Education
- Vasogen Announces Implementation of Strategic Restructuring Plan
- Nutra Pharma Acquires Remaining Interest in Biopharmaceutical Drug Discovery Company - ReceptoPharm, Inc.
April 15, 2008
- AstraZeneca Settles US Nexium Patent Litigation with Ranbaxy
- Shire to Introduce a New UK Listed Holding Company
- Roche Fully Acquires Privately-Owned Biotech Company Piramed
- Forest Laboratories, Inc. Reports Fiscal Year 2008 Fourth Quarter Reported EPS of $0.55 Including $0.35 Per Share Charge for Licensing Payment
- Johnson & Johnson Reports 2008 First-Quarter Results:
- Pfizer Completes Tender Offer for Shares of Encysive Pharmaceuticals Inc.
- Ingenuity Systems and Pfizer Announce Strategic Partnership for Pathway Analysis
- IMS Health Reports Global Prescription Sales Grew 6.4 Percent in 2007, to $712 Billion
- Statins May Help Reduce Blood Pressure
- Merck Responds to Journal of the American Medical AssociationArticles
- Risk of Death from Rofecoxib in Some Trials May Have Been Misrepresented by Study Sponsor
- JAMA Editorial: Impugning the Integrity of Medical Science — the Adverse Effects of Industry Influence
- Use of Ghostwriters, Guest Authors Appears Frequent for Studies Involving Rofecoxib
April 16, 2008
- EMD Serono Announces Planned Investment of $50 Million in Research Center in Massachusetts
- Abbott Reports Double-Digit Sales and Earnings Growth in First Quarter and Reaffirms Full-Year Growth Outlook
- Consumers' Average Prescription Drug Copay Drops as Generic Drug Use Grows
- Linguamatics Announces Expansion of Strategic Collaboration with Pfizer
- Lilly to Streamline Indianapolis Manufacturing and Engineering Operations
- Consumers' Average Prescription Drug Copay Drops as Generic Drug Use Grows
- Covalence: Ethical Ranking 1st Quarter 2008
- Chemizon Announces a Second Expansion of Collaboration with Takeda
- Chromos Provides Shareholder Update
- Gilead Sciences Announces First Quarter 2008 Financial Results
April 17, 2008
- Baxter Reports Solid First Quarter Financial Results and Raises Full-Year Outlook
- FDA Issues
- Pfizer Reports First-Quarter 2008 Results; Reaffirms Full-Year 2008 Financial Guidance
- GlaxoSmithKline and Regulus Therapeutics Form Strategic Alliance To Develop MicroRNA Targeted Therapeutics to Treat Inflammatory Diseases
- Dynogen Pharmaceuticals and Apex Bioventures Mutually Terminate Merger Agreement
- Pfizer and AVANT Enter into Licensing and Development Agreement for Novel Therapeutic Vaccine Candidate for Brain Cancer
- ViroPharma Announces Discontinuation of HCV-796 Development
- Roche Continues Solid Sales Growth in First Quarter of 2008 - Both Divisions Significantly Outpace Their Markets
- Dainippon and Ono Discontinue Development for an Additional Indication of Limaprost Alfadex
- Dynavax and Merck & Co., Inc. Update Status of Clinical Hold ofInvestigational Vaccine Heplisav
- Washington University in St. Louis and AstraZeneca Announce Alzheimer's Research Collaboration
- Growth Hormone is Used to Treat Twice as Many Short Boys Than Girls in the U.S. and Asia; Gender Difference is Smaller in the Rest of the World
- Roche and the Institute for OneWorld Health Announce Research Collaboration to Fight Neglected Diarrheal Diseases in Developing Countries
- Cangene Voluntarily Withdraws One Lot of its Vaccinia Immune Globulin
- HealthOpin III: Fearing Recession, Americans Cut Back on Healthcare Spending
April 18, 2008
- Federal Court in Canada Upholds Pfizer's Norvasc Patent; Decision Prevents Launch of Generic Amlodipine Besylate Product by Pharmascience until 2010
- Energy and Commerce Leaders Release Comprehensive Food and Drug Safety Proposal
- ISS/Risk Metrics Recommends Renovis Shareholders Vote for Merger With Evotec
April 21, 2008
- Novartis Reports Higher Sales and Earnings in First Quarter of 2008 Showing Healthcare Portfolio Well on the Way to New Growth Cycle
- Pfizer Japan Receives Manufacturing and Marketing Authorization for Sutent
- Vytorin Coverage with Leading Health Plans Revisited - See Uptake of Generic Simvastatin and Crestor Without Need for Widespread Formulary Changes
- PCMA: Court of Appeals Upholds Challenge to D.C.'s PBM Fiduciary-Disclosure Law
- Report on 750 New Medicines in Development for Cancer Released in Baton Rouge
April 22, 2008
- Children With ADHD Should Get Heart Tests Before Treatment with Stimulant Drugs
- FDA Warns Pfizer Over Viagra Video
- Confidence in FDA Hits New Low, According to WSJ.com/Harris Interactive Study
- GlaxoSmithKline to Acquire Sirtris Pharmaceuticals, a World Leader in 'Sirtuin' Research and Development
April 23, 2008
- Biogen Idec Reports First Quarter 2008 Results
- Schering-Plough Reports Financial Results for First Quarter of 2008
- GSK Reports Q1 Business Performance EPS of 25.6p
April 24, 2008
- Former Bristol-Myers Squibb Senior Vice President Indicted for Lying to the Federal Government About Popular Blood-Thinning Drug
- AstraZeneca PLC First Quarter Results 2008
- Strong Double-Digit Net Sales Growth and Solid Earnings Growth Highlight First Quarter for Bristol-Myers Squibb Company
- Bayer Off to an Excellent Start in 2008
- Arana and Kyowa Hakko to Co-Develop Anti-Cancer Drug
- Genentech Announces Decision in Contract Dispute
April 25, 2008
- Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance
- Solvay Pharmaceuticals S.A. Launches Friendly Bid to Acquire Innogenetics
- Astellas and CoMentis Sign Agreement to Collaborate on the Research, Development and Commercialization of Beta-Secretase Inhibitors
- Abbott Annual Meeting Highlights Outstanding 2007 Results, International Growth and Near-Term Pipeline
- Pfizer Enters into Research Consortium to Expand Understanding of Diabetes and Obesity Pathobiology
April 28, 2008
- Kyowa Hakko Fiscal 2007 Operating Income up 28.3%: Sales and Operating Income Exceed Plan Targets
- U.S. Government Accepts $192 Million of Sanofi Pasteur H5N1 Bulk Vaccine Antigen for Pandemic Stockpile
April 29, 2008
- Takeda and Millennium Announce Early Termination of Hart-Scott-Rodino Waiting Period
- Hormone Therapy in Postmenopausal Women Associated with Increased Risk of Stroke
